Evidence map›Paper›PMID 26347656›Full record

ArticleFrontiers in physiology2015

Bioregulatory systems medicine: an innovative approach to integrating the science of molecular networks, inflammation, and systems biology with the patient's autoregulatory capacity?

Alyssa W Goldman, Yvonne Burmeister, Konstantin Cesnulevicius, Martha Herbert, Mary Kane, David Lescheid, Timothy McCaffrey, Myron Schultz, Bernd Seilheimer, Alta Smit and 2 more

Abstract read
In one paragraph

Article in Frontiers in physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. The Neuroimmunology of Autism.Molecular neurobiology · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Multiscale modeling in disease.Current opinion in systems biology · 2021
    Article
  8. Regulation of Inflammatory Reaction in Health and Disease.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Clinical Applications of System Regulation Medicine.Open access Macedonian journal of medical sciences · 2019
    Review
  12. Article
  13. Personalized medicine for patients with COPD: where are we?International journal of chronic obstructive pulmonary disease · 2019
    Review
  14. Review
  15. The growth of chronic conditions: Search for solutions to the problem.Chronic diseases and translational medicine · 2017
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Alyssa W GoldmanConcept Systems, Inc. Ithaca, NY, USA ; Department of Sociology, Cornell University Ithaca, NY, USA.
Yvonne BurmeisterBiologische Heilmittel Heel GmbH Baden-Baden, Germany.
Konstantin CesnuleviciusBiologische Heilmittel Heel GmbH Baden-Baden, Germany.
Martha HerbertTranscend Research Laboratory, Massachusetts General Hospital Boston, MA, USA.
Mary KaneConcept Systems, Inc. Ithaca, NY, USA.
David LescheidInternational Academy of Bioregulatory Medicine Baden-Baden, Germany.
Timothy McCaffreyDivision of Genomic Medicine, George Washington University Medical Center Washington, DC, USA.
Myron SchultzBiologische Heilmittel Heel GmbH Baden-Baden, Germany.
Bernd SeilheimerBiologische Heilmittel Heel GmbH Baden-Baden, Germany.
Alta SmitBiologische Heilmittel Heel GmbH Baden-Baden, Germany.
Georges St LaurentSt. Laurent Institute Vancouver, WA, USA.
Brian BermanCenter for Integrative Medicine, University of Maryland School of Medicine Baltimore, MD, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bioregulatory systems medicine (BrSM) is a paradigm that aims to advance current medical practices. The basic scientific and clinical tenets of this approach embrace an interconnected picture of human health, supported largely by recent advances in systems biology and genomics, and focus on the implications of multi-scale interconnectivity for improving therapeutic approaches to disease. This article introduces the formal incorporation of these scientific and clinical elements into a cohesive theoretical model of the BrSM approach. The authors review this integrated body of knowledge and discuss how the emergent conceptual model offers the medical field a new avenue for extending the armamentarium of current treatment and healthcare, with the ultimate goal of improving population health.

Indexed as

autoregulationbioregulatory systems medicinegenomicsinflammationsystems biologysystems medicine

Identifiers

PMID26347656
PMCPMC4541032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.